SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-24-067284
Filing Date
2024-05-31
Accepted
2024-05-31 17:07:28
Documents
18
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A tm2416176d1_10ka.htm   iXBRL 10-K/A 66455
2 EXHIBIT 23.1 tm2416176d1_ex23-1.htm EX-23.1 2456
3 EXHIBIT 23.2 tm2416176d1_ex23-2.htm EX-23.2 2735
4 EXHIBIT 31.1 tm2416176d1_ex31-1.htm EX-31.1 3354
5 EXHIBIT 31.2 tm2416176d1_ex31-2.htm EX-31.2 3317
6 EXHIBIT 32 tm2416176d1_ex32.htm EX-32 5058
  Complete submission text file 0001104659-24-067284.txt   315612

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA ptpi-20231231.xsd EX-101.SCH 3027
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptpi-20231231_lab.xml EX-101.LAB 36884
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptpi-20231231_pre.xml EX-101.PRE 24154
22 EXTRACTED XBRL INSTANCE DOCUMENT tm2416176d1_10ka_htm.xml XML 6685
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39752 | Film No.: 241010746
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)